References to the "Company," "SVF Investment Corp." "our," "us" or "we" refer to
SVF Investment Corp. The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with
the financial statements and the notes thereto contained elsewhere in this
report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have
based these forward-looking statements on our current expectations and
projections about future events. These forward-looking statements are subject to
known and unknown risks, uncertainties and assumptions about us that may cause
our actual results, levels of activity, performance or achievements to be
materially different from any future results, levels of activity, performance or
achievements expressed or implied by such forward-looking statements. In some
cases, you can identify forward-looking statements by terminology such as "may,"
"should," "could," "would," "expect," "plan," "anticipate," "believe,"
"estimate," "continue," or the negative of such terms or other similar
expressions. Factors that might cause or contribute to such a discrepancy
include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated as a Cayman Islands exempted company
on October 5, 2020. We were formed for the purpose of effecting a merger, share
exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses (the "Business Combination"). We are an
emerging growth company and, as such, we are subject to all of the risks
associated with emerging growth companies.
Our sponsor is SVF Sponsor LLC, a Delaware limited liability company (the
"Sponsor"). The registration statement for our Initial Public Offering was
declared effective on January 7, 2021. On January 12, 2021, we consummated its
Initial Public Offering of 60,375,000 units (the "Units" and, with respect to
the Class A ordinary shares included in the Units being offered, the "Public
Shares"), including 7,875,000 additional Units to cover over-allotments (the
"Over-Allotment Units"), at $10.00 per Unit, generating gross proceeds of
approximately $603.8 million, and incurring offering costs of approximately
$33.9 million, of which approximately $21.1 million was deferred underwriting
commissions. On April 22, 2021, the underwriters made a payment to us in an
amount of $600,000 to reimburse certain of our expenses in connection with this
offering.
Simultaneously with the closing of the Initial Public Offering, we consummated
the private placement ("Private Placement") of 9,383,333 warrants (each, a
"Private Placement Warrant" and collectively, the "Private Placement Warrants"),
at a price of $1.50 per Private Placement Warrant with our Sponsor, generating
gross proceeds of approximately $14.1 million.
Upon the closing of the Initial Public Offering and the Private Placement,
approximately $603.8 million ($10.00 per Unit) of the net proceeds of the
Initial Public Offering and certain of the proceeds of the Private Placement
were placed in a trust account ("Trust Account") with Continental Stock
Transfer & Trust Company acting as trustee and invested in United States
"government securities" within the meaning of Section 2(a)(16) of the Investment
Company Act having a maturity of 185 days or less or in money market funds
meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act of 1940, as amended, or the
Investment Company Act. which invest only in direct U.S. government treasury
obligations, as determined by the Company, until the earlier of: (i) the
completion of a Business Combination and (ii) the distribution of the Trust
Account as described below.

                                       20
--------------------------------------------------------------------------------
  Table of Contents
If we are unable to complete a Business Combination within 24 months from the
closing of the Initial Public Offering, or January 12, 2023, (the "Combination
Period"), we will (i) cease all operations except for the purpose of winding up;
(ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to us to pay our income taxes, if any (less up to
$100,000 of interest to pay dissolution expenses), divided by the number of the
then-outstanding Public Shares, which redemption will completely extinguish
Public Shareholders' rights as shareholders (including the right to receive
further liquidation distributions, if any); and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining
shareholders and the board of directors, liquidate and dissolve, subject in the
case of clauses (ii) and (iii), to our obligations under Cayman Islands law to
provide for claims of creditors and the requirements of other applicable law.
Liquidity and Capital Resources
As of March 31, 2021, we had approximately $706,000 in operating cash, and
working capital of approximately $991,000.
Our liquidity needs to date have been satisfied through a contribution of
$25,000 from Sponsor to cover certain expenses in exchange for the issuance of
the Founder Shares, a loan of up to approximately $300,000 from the Sponsor
pursuant to the Note, of which approximately $173,000 was outstanding as of
December 31, 2020 and approximately $296,000 in total prior to the Initial
Public Offering, and subsequent to the Initial Public Offering, the proceeds of
$2.0 million from the consummation of the Private Placement not held in the
Trust Account. We repaid the Note in full on January 13, 2021. In addition, in
order to finance transaction costs in connection with a Business Combination,
the Sponsor or an affiliate of the Sponsor, or certain of our officers and
directors may, but are not obligated to, provide us Working Capital Loans. To
date, there were no amounts outstanding under any Working Capital Loan. As of
March 31, 2021, there was $2.0 million outstanding under the Working Capital
Loan.
Based on the foregoing, management believes that it will have sufficient working
capital and borrowing capacity to meet its needs through the earlier of the
consummation of a business combination or one year from this filing. Over this
time period, we will be using these funds for paying existing accounts payable,
identifying and evaluating prospective initial business combination candidates,
performing due diligence on prospective target businesses, paying for travel
expenditures, selecting the target business to merge with or acquire, and
structuring, negotiating and consummating the business combination.
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that the specific impact is not readily determinable
as of the date of the unaudited condensed financial statements. The unaudited
condensed financial statements do not include any adjustments that might result
from the outcome of this uncertainty.
Results of Operations
Our entire activity since inception up to March 31, 2021 was in preparation for
our formation and the Initial Public Offering. We will not be generating any
operating revenues until the closing and completion of our initial Business
Combination.
For the three months ended March 31, 2021, we had net loss of approximately
$12.6 million, which consisted of general and administrative expenses of
approximately $767,000, general and administrative expenses to related party of
$28.1 million, offering costs associated with derivative liabilities of
approximately $2.6 million, partially offset by change in fair value of
derivative liabilities of approximately $18.8 million and income from
investments held in the Trust Account of approximately $8,000. Of the
approximately $28.1 million in general and administrative expenses with related
parties, $28.1 million is a noncash charge for the excess initial fair value of
Private Placement Warrants over the purchase price for such warrants paid by our
Sponsor.

                                       21
--------------------------------------------------------------------------------
  Table of Contents
Contractual Obligations
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement Warrants, and warrants that
may be issued upon conversion of Working Capital Loans (and any Class A ordinary
shares issuable upon the exercise of the Private Placement Warrants and warrants
that may be issued upon conversion of Working Capital Loans) were entitled to
registration rights pursuant to a registration and shareholder rights agreement.
The holders of these securities were entitled to make up to three demands,
excluding short form demands, that we register such securities. In addition, the
holders have certain "piggy-back" registration rights with respect to
registration statements filed subsequent to the completion of the initial
Business Combination. We will bear the expenses incurred in connection with the
filing of any such registration statements.
Underwriting Agreement
We granted the underwriters a
45-day
option from the date of this prospectus to purchase up to 7,875,000 additional
Units at the Initial Public Offering price less the underwriting discounts and
commissions. On January 12, 2021, the underwriters fully exercised the
over-allotment option.
The underwriters were entitled to an underwriting discount of $0.20 per unit, or
approximately $12.1 million in the aggregate, paid upon the closing of the
Initial Public Offering. In addition, $0.35 per unit, or approximately
$21.1 million in the aggregate will be payable to the underwriters for deferred
underwriting commissions. The deferred fee will become payable to the
underwriters from the amounts held in the Trust Account solely in the event that
we complete a Business Combination, subject to the terms of the underwriting
agreement.
Forward Purchase Agreement
We entered into a forward purchase agreement (a "Forward Purchase Agreement")
with certain investors (the "Forward Purchase Investor"), which provides for the
purchase of $250,000,000 of forward purchase units (the "Forward Purchase
Units"), with each unit consisting of one Class A ordinary share (a "Forward
Purchase Share") and
one-fifth
of one warrant to purchase one Class A ordinary share at $11.50 per share (a
"Forward Purchase Warrant"), for a purchase price of $10.00 per unit, in a
private placement to occur concurrently with the closing of the initial Business
Combination. The Forward Purchase Agreement also provides that the Forward
Purchase Investor may elect to purchase up to an additional $50,000,000 of
Forward Purchase Units, which will also have a purchase price of $10.00 per Unit
and consist of one Class A ordinary share and
one-fifth
of one warrant. Any elections to purchase up to 5,000,000 additional Forward
Purchase Units will take place in one or more private placements in such amounts
and at such time as the Forward Purchase Investor determines, but no later than
simultaneously with the closing of the initial Business Combination. We and the
Forward Purchase Investor may determine, by mutual agreement, to increase the
number of additional Forward Purchase Units at any time prior to the initial
Business Combination. The obligations under the Forward Purchase Agreement do
not depend on whether any Class A ordinary shares are redeemed by the Public
Shareholders. The forward purchase securities will be issued only in connection
with the closing of the initial Business Combination. The proceeds from the sale
of forward purchase securities may be used as part of the consideration to the
sellers in the initial Business Combination, expenses in connection with the
initial Business Combination or for working capital in the post-transaction
company.
Critical Accounting Policies
Derivative liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC
815-15.
The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 12,075,000 warrants issued in connection with the Initial Public Offering
(the "Public Warrants"), the 9,383,333 Private Placement Warrants, the 5,000,000
committed forward purchase warrants and the 1,000,000 additional forward
purchase warrants are recognized as derivative liabilities in accordance with
ASC
815-40.
Accordingly, we recognize the warrant instruments as liabilities at fair value
and adjusts the instruments to fair value at each reporting period. The
liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is
recognized in our unaudited condensed statement of operations. The fair value of
the Public Warrants issued in connection with the Public Offering, Private
Placement Warrants and forward purchase agreement were initially measured at
fair value using a Monte Carlo simulation model and subsequently, the fair value
of the Private Placement Warrants and forward purchase warrants have been
estimated using a Monte Carlo simulation model each measurement date. The fair
value of Public Warrants issued in connection with the Initial Public Offering
have subsequently been measured based on the listed market price of such
warrants.

                                       22
--------------------------------------------------------------------------------
  Table of Contents
Offering Costs Associated with the Initial Public Offering
Offering costs consisted of legal, accounting, underwriting fees and other costs
incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs are allocated to the separable financial
instruments issued in the Initial Public Offering based on a relative fair value
basis, compared to total proceeds received. Offering costs associated with
derivative liabilities are expensed as incurred, presented as
non-operating
expenses in the statement of operations. Offering costs associated with the
Class A ordinary shares were charged to shareholders' equity (deficit) upon the
completion of the Initial Public Offering. For the three months ended March 31,
2021, of the total offering costs of the Initial Public Offering, approximately
$2.6 million is included in offering cost-derivative liabilities in the
unaudited condensed statement of operations and approximately $30.8 million is
included in the unaudited condensed statement of changes in shareholders' equity
(deficit).
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in
accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from
Equity." Class A ordinary shares subject to mandatory redemption (if any) are
classified as liability instruments and are measured at fair value.
Conditionally redeemable Class A ordinary shares (including Class A ordinary
shares that feature redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not
solely within our control) are classified as temporary equity. At all other
times, Class A ordinary shares are classified as shareholders' equity. Our
Class A ordinary shares feature certain redemption rights that are considered to
be outside of the Company's control and subject to the occurrence of uncertain
future events. Accordingly, as of March 31, 2021, 51,037,939 Class A ordinary
shares subject to possible redemption are presented as temporary equity, outside
of the shareholders' equity (deficit) section of our unaudited condense balance
sheets.
Net loss per Ordinary Shares
Net loss per ordinary share is computed by dividing net loss by the
weighted-average number of ordinary shares outstanding during the periods.
Our unaudited condensed statement of operations includes a presentation of loss
per share for ordinary shares subject to possible redemption in a manner similar
to the
two-class
method of loss per ordinary share. Net loss per ordinary share, basic and
diluted, for Class A ordinary shares subject to possible redemption is
calculated by dividing the proportionate share of income or loss from
investments held in Trust Account, net of applicable income taxes, by the
weighted average number of Class A ordinary shares subject to possible
redemption outstanding for the period.
Net loss per ordinary share, basic and diluted, for
non-redeemable
ordinary shares is calculated by dividing the net loss, adjusted for income or
loss from investment attributable to Class A ordinary shares subject to possible
redemption, by the weighted average number of
non-redeemable
ordinary shares outstanding for the period.
Non-redeemable
ordinary shares include Founder Shares and
non-redeemable
shares of Class A ordinary shares as these shares do not have any redemption
features.
Non-redeemable
ordinary shares participate in the income or loss from investments based on
non-redeemable
shares' proportionate interest.
Non-cash
compensation to Sponsor
We record
non-cash
compensation recognized as a result of the fair value of the Private Placement
Warrants being in excess of the amount paid by the Sponsor, pursuant to ASC
718, Share-based Compensation.

                                       23
--------------------------------------------------------------------------------
  Table of Contents
Recent Issued Accounting Standards
Our management does not believe that any recently issued, but not yet effective,
accounting standards updates, if currently adopted, would have a material effect
on the accompanying unaudited condensed financial statements.
Off-Balance
Sheet Arrangements
As of March 31, 2021, we did not have any
off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" and
under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for
non-emerging
growth companies. As a result, the unaudited condensed financial statements may
not be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the
other reduced reporting requirements provided by the JOBS Act. Subject to
certain conditions set forth in the JOBS Act, if, as an "emerging growth
company," we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor's attestation report on our system of
internal controls over financial reporting pursuant to Section 404, (ii) provide
all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer
Protection Act, (iii) comply with any requirement that may be adopted by the
PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's
report providing additional information about the audit and the financial
statements (auditor discussion and analysis) and (iv) disclose certain executive
compensation related items such as the correlation between executive
compensation and performance and comparisons of the CEO's compensation to median
employee compensation. These exemptions will apply for a period of five years
following the completion of our Initial Public Offering or until we are no
longer an "emerging growth company," whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule
12b-2
of the Exchange Act and are not required to provide the information otherwise
required under this item. As of March 31, 2021, we were not subject to any
market or interest rate risk. The net proceeds of the Initial Public Offering,
including amounts in the Trust Account, will be invested in U.S. government
securities with a maturity of 185 days or less or in money market funds that
meet certain conditions under Rule
2a-7
under the Investment Company Act of 1940, as amended, that invest only in direct
U.S. government treasury obligations. Due to the short-term nature of these
investments, we believe there will be no associated material exposure to
interest rate risk.
We have not engaged in any hedging activities since our inception and we do not
expect to engage in any hedging activities with respect to the market risk to
which we are exposed.
Item 4. Controls and Procedures
On April 12, 2021, the staff at the Securities and Exchange Commission (the
"SEC") issued a statement on Accounting and Reporting Considerations for
Warrants Issued by Special Purpose Acquisition Companies ("SPACs") (the "SEC
Statement"). In the SEC Statement, the SEC staff noted that certain provisions
in the typical SPAC warrant agreement may require that the warrants be
classified as a liability measured at fair value, with changes in fair value
reported each period in earnings, as compared to the historical treatment of the
warrants as equity, which has been the practice of most SPACs, including us. We
had previously classified our private placement warrants public warrants and
forward purchase warrants as equity (for a full description of our private
placement warrants, public warrants and forward purchase warrants refer to the
registration statement on Amendment No.2 to Form S-1 (File No. 333-251541),
filed in connection with the Company's initial public offering, declared
effective by the SEC on January 7, 2021).

                                       24
--------------------------------------------------------------------------------
  Table of Contents
After considering the SEC Statement, we concluded that there were misstatements
in the January 12, 2021 audited closing balance sheet we filed with the SEC on
Form
8-K
on January 20, 2021. Based on the guidance in Accounting Standards Codification
("ASC")
815-40,
"Derivatives and Hedging - Contracts in Entity's Own Equity", we concluded that
provisions in the warrant agreement preclude the warrants from being accounted
for as components of equity. As the warrants meet the definition of a derivative
as contemplated in ASC 815, the warrants should have been recorded as derivative
liabilities on the balance sheet and measured at fair value at inception and at
each reporting date in accordance with ASC 820, "Fair Value Measurement", with
changes in fair value recognized in the statement of operations in the period of
change. Further, ASC 815 requires that upfront costs and fees related to items
for which the fair value option is elected (our warrant liabilities) should have
been recognized as expense as incurred.
We have corrected the accounting for the warrants in this Quarterly Report on
Form
10-Q.
The effect of the restatement on specific line items in our January 12, 2021
audited closing date balance sheet can be found in footnote 10 of the Notes to
unaudited condensed Financial Statements.
Evaluation of Disclosure Controls and Procedures
In connection with the restatement of our January 12, 2021 audited closing
balance sheet, our management reassessed the effectiveness of our disclosure
controls and procedures as of March 31, 2021. As a result of that reassessment
and in light of the SEC Statement, our management determined that our disclosure
controls and procedures as of March 31, 2021 were not effective solely as a
result of its classification of the warrants as components of equity instead of
as derivative liabilities.
In light of the material weakness that we identified, we performed additional
analysis as deemed necessary to ensure that our unaudited condensed financial
statements for the three months ended March 31, 2021, were prepared in
accordance with U.S. generally accepted accounting principles. Accordingly,
management believes that the unaudited condensed financial statements included
in this Quarterly Report on Form 10-Q present fairly in all material respects
our financial position, results of operations and cash flows for the period
presented.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such
term is defined in Rules
13a-15(f)
and
15d-15(f)
under the Exchange Act) during the most recent fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting, as the circumstances that led to the
restatement of our previously filed financial statements described above had not
yet been identified.
In light of the restatement of the previously filed financial statements, we
plan to enhance our processes to identify and appropriately apply applicable
accounting requirements to better evaluate and understand the nuances of the
complex accounting standards that apply to our financial statements. Our plans
at this time include providing enhanced access to accounting literature,
research materials and documents and increased communication among our personnel
and third-party professionals with whom we consult regarding complex accounting
applications. The elements of our remediation plan can only be accomplished over
time, and we can offer no assurance that these initiatives will ultimately have
the intended effects.

© Edgar Online, source Glimpses